Elicera Therapeutics AB
€0.27
1
+€0.01+2.9% Today
Statistics
Day High
0.27
Day Low
0.27
52W High
0.69
52W Low
0.26
Volume
-
Avg. Volume
-
Mkt Cap
12.91M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
21AprExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-4.17MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 8E8.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Elicera Therapeutics AB (publ), a clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden. The company's portfolio products in pipeline includes ELC-100 that is in Phase I/IIa clinical trial for neuroendocrine tumors; and ELC-201, which is in preclinical stage for the treatment of various forms of solid cancer. It is also developing ELC-301, a CAR T-cell therapy that is in Phase I/IIa clinical trial for the treatment of Non-Hodgkin's B-cell lymphoma; and ELC-401, a CAR T-cell therapy, which is in preclinical stage for the treatment of brain tumors. Elicera Therapeutics AB (publ) has collaboration with the Vecura R&D division at Karolinska University Hospital and Uppsala University to develop a fully automated production flow of ELC-401 for use in future clinical trials. The company was incorporated in 2014 and is based in Gothenburg, Sweden.
Show more...
CEO
Mr. Jamal El-Mosleh M.Sc.
Employees
3
Country
Sweden
ISIN
SE0015382080
WKN
000A3CSAN
Listings
0 Comments
Share your thoughts
FAQ
What is Elicera Therapeutics AB stock price today?▼
The current price of 8E8.F is €0.27 EUR — it has increased by +2.9% in the past 24 hours. Watch Elicera Therapeutics AB stock price performance more closely on the chart.
What is Elicera Therapeutics AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Elicera Therapeutics AB stocks are traded under the ticker 8E8.F.
Is Elicera Therapeutics AB stock price growing?▼
8E8.F stock has fallen by -7.48% compared to the previous week, the month change is a -45.32% fall, over the last year Elicera Therapeutics AB has showed a -30.64% decrease.
What is Elicera Therapeutics AB market cap?▼
Today Elicera Therapeutics AB has the market capitalization of 12.91M
What is Elicera Therapeutics AB revenue for the last year?▼
Elicera Therapeutics AB revenue for the last year amounts to 0 EUR.
What is Elicera Therapeutics AB net income for the last year?▼
8E8.F net income for the last year is -4.17M EUR.
How many employees does Elicera Therapeutics AB have?▼
As of April 29, 2026, the company has 3 employees.
In which sector is Elicera Therapeutics AB located?▼
Elicera Therapeutics AB operates in the Health & Wellness sector.
When did Elicera Therapeutics AB complete a stock split?▼
Elicera Therapeutics AB has not had any recent stock splits.
Where is Elicera Therapeutics AB headquartered?▼
Elicera Therapeutics AB is headquartered in Gothenburg, Sweden.